Showing 1 - 20 results of 44 for search '"Трансуретральная резекция предстательной железы"', query time: 0.83s Refine Results
  1. 1
  2. 2
    Academic Journal

    Contributors: The research was supported by FASIE (No 19043GU/2023 dated February 21, 2024)., Исследование выполнено при финансовой поддержке Фонда содействия инновациям (№ 19043ГУ/2023 от 21 февраля 2024 года).

    Source: Urology Herald; Том 12, № 2 (2024); 23-32 ; Вестник урологии; Том 12, № 2 (2024); 23-32 ; 2308-6424 ; 10.21886/2308-6424-2024-12-2

    File Description: application/pdf

    Relation: https://www.urovest.ru/jour/article/view/852/547; Hrbacek J, Tlaskal V, Cermak P, Hanacek V, Zachoval R. Bladder Microbiota Are Associated with Clinical Conditions That Extend beyond the Urinary Tract. Microorganisms. 2022;10(5):874. DOI:10.3390/microorganisms10050874; Naboka YL, Mavzyutov AR, Kogan MI, Gudima IA, Dzhalagoniya KT, Ivanov SN, Naber KG. The gene profile of Enterobacteriaceae virulence factors in relation to bacteriuria levels between the acute episodes of recurrent uncomplicated lower urinary tract infection. Expert Rev Anti Infect Ther. 2021;19(8):1061-1066. DOI:10.1080/14787210.2021.1866986; Tenney J, Hudson N, Alnifaidy H, Li JTC, Fung KH. Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharm J. 2018;26(5):678-684. DOI:10.1016/j.jsps.2018.02.023; Коган М.И., Набока Ю.Л., Иванов С.Н. Факторы риска, антибиотикопрофилактика и лечение инфекции мочевых путей при трансуретральной хирургии гиперплазии простаты. Вестник урологии. 2022;10(2):99-108. DOI:10.21886/2308-6424-2022-10-2-99-108; Kot B, Grużewska A, Szweda P, Wicha J, Parulska U. Antibiotic Resistance of Uropathogens Isolated from Patients Hospitalized in District Hospital in Central Poland in 2020. Antibiotics (Basel). 2021;10(4):447. DOI:10.3390/antibiotics10040447; Иванов С.Н., Коган М.И., Набока Ю.Л., Медведев В.Л. Инфекционный фактор при трансуретральной хирургии доброкачественной гиперплазии простаты: систематический обзор и мета-анализ. Урология. 2023;(4):141-149. DOI:10.18565/urology.2023.4.141-149; Козлов Р.С., Меньшиков В.В., Михайлова В.С., Шуляк Б.Ф., Долгих Т.И., Круглов А.Н., Алиева Е.В., Маликова В.Е. Бактериологический анализ мочи. Клинические рекомендации. М.; 2014.; Agbugui JO, Obarisiagbon EO, Osaigbovo II. Bacteriology of Urine Specimens Obtained from Men with Symptomatic Benign Prostatic Hyperplasia. Niger J Surg. 2016;22(2):65-69. DOI:10.4103/1117-6806.177415; Behcet M, Avcioglu F. Causative Agents of Urinary Tract Infections in Elderly Men with Benign Prostatic Hyperplasia: a Microbiological Evaluation. Clin Lab. 2021;67(6). DOI:10.7754/Clin.Lab.2020.200940; Dybowski BA, Zapała P, Bres-Niewada E, Zapała Ł, Miązek-Zapała N, Poletajew S, Młynarczyk G, Radziszewski P. Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern. BMC Infect Dis. 2018;18(1):590. DOI:10.1186/s12879-018-3507-9; Mishra PP, Prakash V, Singh K, Mog H, Agarwal S. Bacteriological Profile of Isolates From Urine Samples in Patients of Benign Prostatic Hyperplasia and or Prostatitis Showing Lower Urinary Tract Symptoms. J Clin Diagn Res. 2016;10(10):DC16-DC18. DOI:10.7860/JCDR/2016/21973.8734; https://www.urovest.ru/jour/article/view/852

  3. 3
    Academic Journal

    Source: Urology Herald; Том 12, № 1 (2024); 19-26 ; Вестник урологии; Том 12, № 1 (2024); 19-26 ; 2308-6424 ; 10.21886/2308-6424-2024-12-1

    File Description: application/pdf

    Relation: https://www.urovest.ru/jour/article/view/826/530; Jo JK, Shinn SH, Kim KS, Moon HS. Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea. Int Neurourol J. 2021;25(4):347-354. DOI:10.5213/inj.2040412.206; Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Chen CL, Tsui KH. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatr. 2018;18(1):15. DOI:10.1186/s12877-018-0709-3; Vivien A, Lazard T, Rauss A, Laisné MJ, Bonnet F. Infection after transurethral resection of the prostate: variation among centers and correlation with a long-lasting surgical procedure. Association pour la Recherche en AnesthésieRéanimation. Eur Urol. 1998;33(4):365-369. DOI:10.1159/000019617; Guo RQ, Yu W, Meng YS, Zhang K, Xu B, Xiao YX, Wu SL, Pan BN. Correlation of benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate. Kaohsiung J Med Sci. 2017;33(3):144-151. DOI:10.1016/j.kjms.2017.01.002; Mayer EK, Kroeze SG, Chopra S, Bottle A, Patel A. Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes. BJU Int. 2012;110(11):1595-1601. DOI:10.1111/j.1464-410X.2012.11119.x; Osman T, ElSaeed KO, Youssef HA, Shabayek M, Emam A, Hussein MS. Evaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria. Arab J Urol. 2017;15(3):260-266. DOI:10.1016/j.aju.2017.05.004; El Basri A, Petrolekas A, Cariou G, Doublet JD, Hoznek A, Bruyere F. Clinical significance of routine urinary bacterial culture after transurethral surgery: results of a prospective multicenter study. Urology. 2012;79(3):564-569. DOI:10.1016/j.urology.2011.11.018; Girou E, Rioux C, Brun-Buisson C, Lobel B; Infection Committee of the French Association of Urology. The postoperative bacteriuria score: a new way to predict nosocomial infection after prostate surgery. Infect Control Hosp Epidemiol. 2006;27(8):847-854. DOI:10.1086/506398; Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG; Working Group "Urological Infections" of German Society of Urology. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/ sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur Urol. 2005;47(4):549-556. DOI:10.1016/j.eururo.2005.01.004; Коган М.И., Набока Ю.Л., Иванов С.Н. Факторы риска, антибиотикопрофилактика и лечение инфекции мочевых путей при трансуретральной хирургии гиперплазии простаты. Вестник урологии. 2022;10(2):99-108. DOI:10.21886/2308-6424-2022-10-2-99-108; Коган М.И., Набока Ю.Л., Иванов С.Н. Оценка инфекционного фактора при трансуретральной хирургии гиперплазии простаты. Вестник урологии. 2021;9(3):79-91. DOI:10.21886/2308-6424-2021-9-3-79-91; Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force. USA, Rockville: Agency for Healthcare Research and Quality (US); 2018.; Arjunlal TS, Deepanjali S, Manikandan R, Medha R. Frequency and clinical significance of prostatic involvement in men with febrile urinary tract infection: a prospective observational study. F1000Res. 2020;9:617. DOI:10.12688/f1000research.24094.3; Иванов С.Н., Коган М.И., Набока Ю.Л., Медведев В.Л. Инфекционный фактор при трансуретральной хирургии доброкачественной гиперплазии простаты: систематический обзор и мета-анализ. Урология. 2023;(4):141-149. DOI:10.18565/urology.2023.4.141-149; Coric J, Mujic J, Kucukalic E, Ler D. Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men. Open Biochem J. 2015;9:34-36. DOI:10.2174/1874091X01509010034; https://www.urovest.ru/jour/article/view/826

  4. 4
  5. 5
    Academic Journal

    Source: Медицинский совет, Vol 0, Iss 19, Pp 8-23 (2014)

    Subject Terms: Male, лазерная простатэктомия, десмопрессин, Phosphodiesterase Inhibitors, Urology, трансуретральная резекция предстательной железы, трансуретральная микроволновая терапия, Prostatic Hyperplasia, Muscarinic Antagonists, антагонисты а-адренергических рецепторов, Severity of Illness Index, 03 medical and health sciences, трансуретральное рассечение предстательной железы, 5-alpha Reductase Inhibitors, 0302 clinical medicine, Lower Urinary Tract Symptoms, антагонисты мускариновых рецепторов, открытая простатэктомия, Humans, доброкачественная гиперплазия предстательной железы, ингибиторы фосфоди-эстеразы, Watchful Waiting, простатический стент, ингибиторы 5а-редуктазы, трансуретральная игольчатая абляция, Transurethral Resection of Prostate, инъекции ботулинового токсина, 3. Good health, Treatment Outcome, симптомы со стороны нижних мочевыводящих путей, Adrenergic alpha-1 Receptor Antagonists, Medicine, Urological Agents, Stents, биполярная трансуретральная резекция предстательной железы, Urinary Catheterization, инъекции этанола, Risk Reduction Behavior

    Linked Full Text
  6. 6
    Academic Journal

    Source: Urology Herald; Том 7, № 2 (2019); 85-92 ; Вестник урологии; Том 7, № 2 (2019); 85-92 ; 2308-6424 ; 10.21886/2308-6424-2019-7-2

    File Description: application/pdf

    Relation: https://www.urovest.ru/jour/article/view/256/208; Unnikrishnan R, Almassi N, Fareed K. Benign prostatic hyperplasia: evaluation and medical management in primary care. Cleve Clin J Med. 2017;84:53-64. DOI:10.3949/ccjm.84a.16008; Ильяш А.В., Чибичян M.Б., Коган М.И. Рак предстательной железы, выявленный при оперативном лечении аденомы. Урология. 2012;1:54-58. eLIBRARY ID: 17706087; Na R, Helfand BT, Chen H, Conran CA, Crawford SE , Hayward SW , Tammela T, Hoffman-Bolton J, Zheng SL , Walsh PC, Schleutker J, Platz EA , Isaacs WB, Xu J. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Prostate 2017;77:1213-1220. DOI:10.1002/pros.23380; Qian X, Liu H, Xu D, Xu L, Huang F, He W, Qi J, Zhu Y, Xu D. Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and meta-analysis. Aging Male. 2017;20(3):184-191. DOI:10.1080/13685538.2017.1295436; Rieken M, Kaplan SA. Enucleation, Vaporization, and Resection: How To Choose the Best Surgical Treatment Option for a Patient with Male Lower Urinary Tract Symptoms. Eur Urol Focus. 2018;4(1):8-10. DOI:10.1016/j.euf.2018.04.020; Stone BV, Chughtai B, Kaplan SA, Te AE, Lee RK. GreenLight laser for prostates over 100 ml: what is the evidence? Curr Opin Urol. 2016;26(1):28-34. DOI:10.1097/MOU.0000000000000237; Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratz-ke C, McVary K, Novara G, Woo H, Madersbacher S. A systematic review and metaanalysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulti ng from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066-1096. DOI:10.1016/j.eururo.2014.06.017; Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR: Combination Holmium and Nd:YAG laser ablation of the prostate: Initial clinical experience. J Endourol. 1995;9:151-153. DOI:10.1089/end.1995.9.151; Chun SS, Razvi HA, Denstedt JD. Laser prostatectomy with the holmium: YAG laser. Techn Urol. 1995;1:217-221. PMID: 9118394; Gilling PJ, Fraundorfer MR. Holmium laser prostatectomy: a technique in evolution. CurrOpin Urol. 1998;8(1):11-15. PMID: 17035836.; Tubaro A, de Nunzio C. The current role of open surgery in BPH. EAU-EBU Update Series. 2006;4:191-201. DOI:10.1016/j.eeus.2006.07.002; Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg. 2007;94:1201-1208. DOI:10.1002/bjs.5916; Elkoushy MA, Elshal AM, Elhilali MM. Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event Analysis. J Endourol. 2015;29(7):797-804. DOI:10.1089/end.2015.0060; Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010;28(1):45-51. DOI:10.1007/s00345-009-0503-0; Kyriazis II,'Swiniarski PP, Jutzi S, Wolters M, Netsch C, Burchardt M, Liatsikos E, Xia S, Bach T, Gross AJ, Herrmann TR. Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement. World J Urol. 2015;33(4):525-530. DOI:10.1007/s00345-015-1529-0; Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology. 1997;49(5):703-708. DOI:10.1016/s0090-4295(97)00232-x; Chughtai B, Te A. Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices. 2011;8(5):591-595. DOI:10.1586/erd.11.25.; Lee DJ, Rieken M, Halpern J, Zhao F, Pueschel H, Chughtai B, Kaplan SA, Lee RK, Bachmann A, Te AE. Laser vaporization of the prostate with the 180-W XPS-Greenlight laser in patients with ongoing platelet aggregation inhibition and oral anticoagulation. Urology. 2016;91:167-173. DOI:10.1016/j.urology.2016; Tao H, Jiang YY, Jun Q, Ding X, Jian DL, Jie D, Ping ZY. Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate. Int Braz J Urol. 2016;42(2):302-311. DOI:10.1590/S1677-5538.IBJU.2014.0500; Michielsen DP, Coomans D. Urethral strictures and bipolar transurethral resection in saline of the prostate: fact or fiction? J Endourol. 2010;24(8):1333-7. DOI:10.1089/end.2009.0575; Lee YH, Chiu AW, Huang JK. Comprehensive study of bladder neck contracture after transurethral resection of prostate. Urology. 2005;65:498-503;discussion 503. DOI:10.1016/j.urol-ogy.2004.10.082; Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, Reich O, Gasser TC, Bachmann A. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int. 2008;102:1432-8;discus-sion 1438-1439. DOI:10.1111/j.1464-410X.2008.07905.x; Nielsen KK, Nordling J. Urethral stricture following transurethral prostatectomy. Urology. 1990;35:18-24. DOI:10.1016/0090-4295(90)80005-8; Hammarsten J, Lindqvist K, Sunzel H. Urethral strictures following transurethral resection of the prostate. The role of the catheter. Br J Urol. 1989;63(4):397-400. PMID: 2713622; Goodwin MI, Chester JF. Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three-way catheters. Ann R Coll Surg Engl. 1990;72(2):125-157. PMID: 2185681; Tan GH, Shah SA, Ali NM, Goh EH, Singam P, Ho CCK, Zainuddin ZM. Urethral strictures after bipolar transurethral resection of prostate may be linked to slow resection rate. Investig Clin Urol. 2017;58(3):186-191. DOI:10.4111/icu.2017.58.3.186; Греченков А.С., Жарикова Т.М. Сахарный диабет как один из факторов риска развития стриктур уретры после трансуретральной резекции простаты. Медицинский вестник Башкортостана. 2015;10(3):24-27. eLIBRARY ID: 24245580; Song W, Wang T, Ling Q, Liu XM, Chen Z, Song XD, Guo XL, Zhuang QY, Wang SG, Liu JH.Thulium laser vaporization versus transurethral resection of the prostate and risk factors for postoperative urethral stricture. Zhonghua Nan Ke Xue. 2017;23(12):1085-1088. PMID: 29738178; Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol. 2006;50:569-573. DOI:10.1016/S0084-4071(08)70089-7; Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, Valenti S, Vavassori I, Rigaffi P. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2008;179(5 Suppl):S87-90. DOI:10.1016/j.juro.2008.03.143; Ukhal MI. Оп the advisability of reinforcing pathogenetically substantiated medication prophylaxis for complications after surgical treatment of prostatic hyperplasia. Health of Men. 2017;4(63):48-50. DOI:10.30841/2307-5090.4(63); Филимонов В.Б., Васин Р.В., Собенников И.С. Рост антибиотикорезистентности микроорганизмов у больных доброкачественной гиперплазией простаты как медико-социальная проблема. Наука молодых (Eruditio Juvenium). 2019;7(1):106-112. eLIBRARY ID: 37145223; Wagenlehner FME, Wagenlehner C, Schinzel S, Naber KG. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levoflox-acin versus 1920 mg trimethoprim/ sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur. Urol. 2005;47:549-556. DOI:10.1016/j.eururo.2005.01.004; Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384-397. DOI:10.1016/j.eururo.2010.06.005; Kikuchi M, Kameyama K, Yasuda M, Yokoi S, Deguchi T, Miwa K. Postoperative infectious complications in patients undergoing holmium laser enucleation of the prostate: Risk factors and microbiological analysis. Int J Urol. 2016;23(9):791-796. DOI:10.1111/iju.13139; Нашивочникова Н.А., Крупин В.Н., Клочай В.В. Состояние микроциркуляции шейки мочевого пузыря у больных ДГПЖ. Медицинский вестник Башкортостана. 2011;6(2):267-271. eLIBRARY ID: 16332168; Sun F, Sun X, Shi Q, Zhai Y. Transurethral procedures in the treatment of benign prostatic hyperplasia: A systematic review and meta-analysis of effectiveness and complications. Medicine (Baltimore). 2018;97(51):e13360. DOI:10.1097/MD.0000000000013360.; Yang Z, Wang X, Liu T. Thulium laser enucleation versus plas-makinetic resection of the prostate: a randomized prospective trial with 18-month follow-up. Urology. 2013;81:396-400. DOI:10.1016/j.urology.2012.08.069; Zhang FB, Shao Q, Tian Y. Comparison of the diode laser and the thulium laser in transurethral enucleation of the prostate for treatment of benign prostatic hyperplasia. Beijing Da Xue Xue Bao. 2013;45:592-596. PMID: 23939169; Thomas JA, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitan C, Knispel H, Bach-mann A. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69:94-102. DOI:10.1016/j.eururo.2015.07.054; Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, Shokeir AA. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010;58:349-355. DOI:10.1016/j.eururo.2010.05.026; Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011;60:734-739. DOI:10.1016/j.eururo.2011.05.043; Захматов Ю.М., Варенцов Г.И., Ответчиков А.И., Корнев А.И. Динамика IPSS после различных видов оперативного лечения ДГПЖ. В кн.: Материалы Х российского съезда урологов. М; 2002; с. 112-114.; Сорокин Д.А., Пучкин А.Б., Семенычев Д.В., Карпухин И.В., Кочкин А.Д., Зорин Д.Г., Севрюков Ф.А. Гиалуроновая кислота в лечении и профилактике послеоперационных осложнений эндоскопических операций по поводу доброкачественной гиперплазии предстательной железы. СТМ. 2015;7(4). eLIBRARY ID: 25140936; Абаев Ю.К. Сахарный диабет и раневое заживление. Медицинский журнал. 2010;1(31):107-110. eLIBRARY ID: 21039075; https://www.urovest.ru/jour/article/view/256

  7. 7
    Academic Journal

    Source: Медицинский совет, Vol 0, Iss 19, Pp 8-23 (2014)

    File Description: electronic resource

  8. 8
    Academic Journal

    Source: Scientific studies: from theory to practice; № 1(11); 60-64 ; Научные исследования: от теории к практике; № 1(11); 60-64 ; ISSN: 2413-3957 ; 2413-3957

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/pissn/2413-3957; https://interactive-plus.ru/e-articles/339/Action339-117966.pdf; 1. Сайт «Реализация областной целевой программы «Развитие здравоохранения Воронежской области на 2011–2015 годы» подпрограммы «Урология» в БУЗ ВОВОКБ №1» [Электронный ресурс]. – Режим доступа: http://www.oblzdrav.vrn.ru; 2. Ранняя диагностика доброкачественной гиперплазии предстательной железы как фактор снижения третичной профилактики / О.И. Аполихин, И.А. Шадёркин, А.В. Щукин, О.В. Золотухин, Ю.Ю. Мадыкин, М.В. Кочетов, Ю.А. Аносова // Вестник новых медицинских технологий. – 2014. – №1. Публикация 2–105 [Электронный ресурс]. – Режим доступа: http://www.medtsu.tula.ru/VNMT/Bulletin/E2014–1/4942.pdf (дата обращения: 17.11.2014).; 3. Формирование долгосрочной модели реструктуризации коечного фонда по профилю Урология на примере Воронежской области / Е.Е. Образцова, В.М. Иванов, О.В. Золотухин, И.А. Шадёркин, Ю.А. Аносова, Ю.Ю. Мадыкин, М.В. Кочетов // Экспериментальная и клиническая урология. – №2. – 2015. – С. 14–19.

  9. 9
    Academic Journal

    Source: Andrology and Genital Surgery; Том 17, № 1 (2016); 20-22 ; Андрология и генитальная хирургия; Том 17, № 1 (2016); 20-22 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2016-17-1

    File Description: application/pdf

    Relation: https://agx.abvpress.ru/jour/article/view/171/162; Лопаткин Н. А. Доброкачественная гиперплазия предстательной железы. М., 1999. 215 с. [Lopatkin N. А. Benign prostate hyperplasia. Мoscow, 1999. 215 p. (In Russ.)].; Мартов А. Г., Лопаткин Н. А. Руководство по трансуретральной эндоскопической электрохирургии аденомы простаты. М.: Триада-Х, 1997. С. 95–103. [Маrtov А. G., Lopatkin N. А. Guidelines for transurethral endoscopic prostate adenoma. Мoscow: Тriadа-Х, 1997. Pp. 95–103. (In Russ.)].; Попов С. В., Бурлака О. О., Вязовцев П. В. Наш опыт выполнения транс уретральной энуклеации доброкачественной гиперплазии предстательной железы. В сб.: Второй российский конгресс по эндо урологии и новым технологиям. Материалы конгресса. М., 2010. С. 143–4. [Popov S. V., Burlakа О. О., Vyazovtsev P. V. Our experience in the performance of the transurethral hyperplasia of the prostate. In: Second Russian congress on endouro logy and new technologies. Congress materials. Мoscow, 2010. Pp. 143–4. (In Russ.)].; Севрюков Ф. А., Сорокин Д. А., Чебыкин А. В. и др. Трансуретральная энуклеация простаты (TUEB) – альтернатива открытой аденомэктомии. В сб.: Второй российский конгресс по эндоурологии и новым технологиям. Материалы конгресса. М., 2010. С. 149–51. [Sevryukov F. А., Sorokin D. А., Chebykin А. V. et al. Тransurethral enucleation of the prostate (TUEB) – аlternative for the open adenectomia. In: Second Russian congress on endourology and new technologies. Congress materials. Мoscow, 2010. Pp. 149–51. (In Russ.)].; Miki M., Shiozawa H., Matsumoto Т., Aizawa T. Transurethral resection in saline (TURis): a newly developed TUR system preventing obturator nerve reflex. Nihon Hinyokika Gakkai Zasshi 2003;94(7):671–7.; Nakagava K. TUEB Procedures. Japan J Urol Surg 2008;21(6):783–7.; Nakagava K. A new minimally invasive medical treatment for prostatic hyperplasia: its current situation and actual practice of the operation; TUEB. Urology View 2007;(5):95–7.; https://agx.abvpress.ru/jour/article/view/171

  10. 10
  11. 11
    Academic Journal

    Source: Bukovinian Medical Herald; Vol. 18 No. 3 (71) (2014) ; Буковинский медицинский вестник; Том 18 № 3 (71) (2014) ; Буковинський медичний вісник; Том 18 № 3 (71) (2014) ; 2413-0737 ; 1684-7903

    File Description: application/pdf

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20